The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection
Open accessAbstract
BACKGROUND: Intravenous (IV), intramuscular (IM), and subcutaneous (SC) are the three most frequently used injection routes in medication administration. Comparative studies of SC versus IV, IM versus IV, or IM versus SC have been sporadically conducted, and some new findings are completely different from the dosage recommendation as described in prescribing information. However, clinicians may still be ignorant of such new evidence-based findings when choosing treatment methods. METHODS: A literature search was performed using PubMed, MEDLINE, and Web of Sciences™ Core Collection to analyze the advantages and disadvantages of SC, IV, and IM administration in head-to-head comparative studies. RESULTS: "SC better than IV" involves trastuzumab, rituximab, antitumor necrosis factor medications, bortezomib, amifostine, recombinant human granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, recombinant interleukin-2, immunoglobulin, epoetin alfa, heparin, and opioids. "IV better than SC" involves ketamine, vitamin K1, and abatacept. With respect to insulin and ketamine, whether IV has advantages over SC is determined by specific clinical circumstances. "IM better than IV" involves epinephrine, hepatitis B immu-noglobulin, pegaspargase, and some antibiotics. "IV better than IM" involves ketamine, morphine, and antivenom. "IM better than SC" involves epinephrine. "SC better than IM" involves interferon-beta-1a, methotrexate, human chorionic gonadotropin, hepatitis B immunoglobulin, hydrocortisone, and morphine. Safety, efficacy, patient preference, and pharmacoeconomics are four principles governing the choice of injection route. Safety and efficacy must be the preferred principles to be considered (eg, epinephrine should be given intramuscularly during an episode of systemic anaphylaxis). If the safety and efficacy of two injection routes are equivalent, clinicians should consider more about patient preference and pharmacoeconomics because patient preference will ensure optimal treatment adherence and ultimately improve patient experience or satisfaction, while pharmacoeconomic concern will help alleviate nurse shortages and reduce overall health care costs. Besides the principles, the following detailed factors might affect the decision: patient characteristics-related factors (body mass index, age, sex, medical status [eg, renal impairment, comorbidities], personal attitudes toward safety and convenience, past experience, perception of current disease status, health literacy, and socioeconomic status), medication administration-related factors (anatomical site of injection, dose, frequency, formulation characteristics, administration time, indication, flexibility in the route of administration), and health care staff/institution-related factors (knowledge, human resources). CONCLUSION: This updated review of findings of comparative studies of different injection routes will enrich the knowledge of safe, efficacious, economic, and patient preference-oriented medication administration as well as catching research opportunities in clinical nursing practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Furnary, A. P., Zerr, K. J., Grunkemeier, G. L., & Starr, A. (1999) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(99)00014-4 · Cited by 1,230
Moreau, P., Pylypenko, H., Grosicki, S., Karamanesht, I., Leleu, X., Grishunina, M., Rekhtman, G., Masliak, Z., Robak, T., Shubina, A., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70081-x · Cited by 920
Epinephrine absorption in adults: Intramuscular versus subcutaneous injection
Simons, F. E. R., Gu, X., & Simons, K. J. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.119409 · Cited by 511
Epinephrine absorption in children with a history of anaphylaxis
Simons, F. E. R., Roberts, J. R., Gu, X., & Simons, K. J. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70190-3 · Cited by 413
Efficacy and safety of once-weekly bortezomib in multiple myeloma patients
Bringhen, S., Larocca, A., Rossi, D., Cavalli, M., Genuardi, M., Ria, R., Gentili, S., Patriarca, F., Nozzoli, C., Levi, A., et al. (2010) · Blood · doi:10.1182/blood-2010-07-294983 · Cited by 381
Pivot, X., Gligorov, J., Müller, V., Barrett-Lee, P., Verma, S., Knoop, A., Curigliano, G., Semiglazov, V., López-Vivanco, G., Jenkins, V., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70383-8 · Cited by 230
Abolhassani, H., Sadaghiani, M. S., Aghamohammadi, A., Ochs, H. D., & Rezaei, N. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9720-1 · Cited by 185
Pivot, X., Gligorov, J., Müller, V., Curigliano, G., Knoop, A., Verma, S., Jenkins, V., Scotto, N., Osborne, S., Fallowfield, L., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu364 · Cited by 177
Intravenous versus Subcutaneous Drug Administration. Which Do Patients Prefer? A Systematic Review
Stoner, K. L., Harder, H., Fallowfield, L. J., & Jenkins, V. A. (2015) · The Patient - Patient-Centered Outcomes Research · doi:10.1007/s40271-014-0075-y · Cited by 174
Besarab, A., Reyes, C. M., & Hornberger, J. C. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.34881 · Cited by 151
Wasserman, R. L., Melamed, I., Stein, M. R., Gupta, S., Puck, J. M., Engl, W., Leibl, H., McCoy, B., Empson, V. G., Gelmont, D. M., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.06.021 · Cited by 151
Arnulf, B., Pylypenko, H., Grosicki, S., Karamanesht, I., Leleu, X., van de Velde, H., Feng, H., Cakana, A., Deraedt, W., & Moreau, P. (2012) · Haematologica · doi:10.3324/haematol.2012.067793 · Cited by 127
Raj, G., Kumar, R., & McKinney, W. P. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.22.2721 · Cited by 127
Roback, M. G., Wathen, J. E., MacKenzie, T. A., et al. (2006) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2006.06.001 · Cited by 121
Jackisch, C., Kim, S.-B., Semiglazov, V., Melichar, B., Pivot, X., Hillenbach, C., Stroyakovskiy, D., Lum, B. L., Elliott, R., Weber, H. A., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdu524 · Cited by 114
Halpern, R., Agarwal, Dembek, C., & Borton (2011) · Patient Preference and Adherence · doi:10.2147/ppa.s15702 · Cited by 110
Weiss, L. G., Clyne, N., Fihlho, J. D., Frisenette‐Fich, C., Kurkus, J., & Svensson, B. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.12.2014 · Cited by 110
Kagan, L., Turner, M. R., Balu‐Iyer, S. V., & Mager, D. E. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0578-3 · Cited by 106
Brooks, P. J., Spruill, W. J., Parish, R. C., & Birchmore, D. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330112 · Cited by 103
Salar, A., Avivi, I. M., Bittner, B., Bouabdallah, R., Brewster, M., Catalani, O., Follows, G., Haynes, A., Hourcade‐Potelleret, F., Janíková, A., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.2631 · Cited by 99
Calabrese, M., Bernardi, V., Atzori, M., Mattisi, I., Favaretto, A. G., Rinaldi, F., de Perini, P., & Gallo, P. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458510394702 · Cited by 90
Martin, A., Lavoie, L., Goetghebeur, M. M., & Schellenberg, R. R. (2012) · Transfusion Medicine · doi:10.1111/j.1365-3148.2012.01201.x · Cited by 88
Moreau, P., Karamanesht, I., Domnikova, N. P., Kyselyova, M., Vilchevska, K. V., Doronin, V., Schmidt, A., Hulin, C., Leleu, X. P., Esseltine, D.-L. W., et al. (2012) · Clinical Pharmacokinetics · doi:10.1007/s40262-012-0010-0 · Cited by 87
Subcutaneous hydrocortisone administration for emergency use in adrenal insufficiency
Hahner, S., Burger-Stritt, S., & Allolio, B. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-1057 · Cited by 81
Gardulf, A., Björvell, H., Andersen, V., Björkander, J., Ericson, D., Frøland, S. S., Gustafson, R., Hammarström, L. L. G., Nystrom, T., Søeberg, B., et al. (1995) · Journal of Advanced Nursing · doi:10.1046/j.1365-2648.1995.21050917.x · Cited by 79
Subcutaneous Drug Delivery: A Route to Increased Safety, Patient Satisfaction, and Reduced Costs
Dychter, S. S., Gold, D. A., & Haller, M. F. (2012) · Journal of Infusion Nursing · doi:10.1097/nan.0b013e31824d2271 · Cited by 78
Harb, G., Lebel, F. M., Battikha, J. P., & Thackara, J. W. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903432900 · Cited by 74
Patients' Attitude to Subcutaneous Immunoglobulin Substitution as Home Therapy
Kittner, J. M., Grimbacher, B., Wulff, W., Jäger, B., & SCHMIDT, R. E. (2006) · Journal of Clinical Immunology · doi:10.1007/s10875-006-9031-5 · Cited by 73
Rule, S., Collins, G. P., & Samanta, K. (2014) · Journal of Medical Economics · doi:10.3111/13696998.2014.914033 · Cited by 66
Tveita, T., Thoner, J., Klepstad, P., Dale, O., Jystad, Å., & Borchgrevink, P. C. (2008) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2008.01608.x · Cited by 55
Pezzarossa, A., Taddei, F., Cimicchi, M. C., Rossini, E., Contini, S., Bonora, E., GNUDI, A., & Uggeri, E. (1988) · Diabetes Care · doi:10.2337/diacare.11.1.52 · Cited by 55
Comparison of allergic reactions to pegasparaginase given intravenously versus intramuscularly
Pidaparti, M., & Bostrom, B. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23380 · Cited by 47
Pharmacokinetics of Human Chorionic Gonadotropin Injection in Obese and Normal-Weight Women
Shah, D. K., Missmer, S. A., Correia, K. F. B., & Ginsburg, E. S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4086 · Cited by 46
Daoust, R., Paquet, J., Lavigne, G. J., Piette, É., & Chauny, J. (2015) · Pain Research and Management · doi:10.1155/2015/316275 · Cited by 46
Haymore, B. R., Carr, W., & Frank, W. T. (2006) · PubMed · Cited by 46
Subcutaneous and intravenous ceftriaxone administration in patients more than 75 years of age
Gauthier, D., Schambach, S., Crouzet, J., Sirvain, S., & Fraisse, T. (2014) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2014.03.007 · Cited by 43
Thomas, J. R., Wallace, M. S., Yocum, R. C., Vaughn, D. E., Haller, M. F., & Flament, J. (2009) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2009.03.009 · Cited by 41
Doyle, M. K., Rahman, M. U., Frederick, B., Birbara, C. A., de Vries, D., Toedter, G., Wu, X., Chen, D., Ranganath, V. K., Westerman, M. E., et al. (2013) · Rheumatology · doi:10.1093/rheumatology/kes381 · Cited by 40
Subcutaneous Versus Intravenous Bortezomib
Barbee, M. S., Harvey, R. D., Lonial, S., Kaufman, J. L., Wilson, N. M., McKibbin, T., Hutcherson, D. A., Surati, M. J., Valla, K., & Shah, K. S. (2013) · Annals of Pharmacotherapy · doi:10.1177/1060028013503122 · Cited by 40
Gerth, W. C., Betschel, S., & Zbrozek, A. S. (2014) · Allergy Asthma and Clinical Immunology · doi:10.1186/1710-1492-10-23 · Cited by 39
Ellis, R. M., Sprivulis, P., Jelinek, G. A., Banham, N. D. G., Wood, S. V., Wilkes, G., Siegmund, A., & Roberts, B. (2005) · Emergency Medicine Australasia · doi:10.1111/j.1742-6723.2005.00720.x · Cited by 38
Ducruet, T., Levasseur, M.-C., Roches, A. D., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.08.022 · Cited by 36
Moreau, P., Pylypenko, H., Grosicki, S., Karamanesht, I., Leleu, X. P., Rekhtman, G. B., Masliak, Z., Robak, P. J., Esseltine, D.-L. W., Feng, H., et al. (2015) · Haematologica · doi:10.3324/haematol.2014.118182 · Cited by 35
Geertsen, P. F., Gore, M. E., Négrier, S., Tourani, J. M., & von der Maase, H. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601709 · Cited by 34
Isbister, G. K., O’Leary, M. A., Miller, M., Brown, S. G. A., Ramasamy, S., James, R., & Schneider, J. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.03004.x · Cited by 34
Efficacy and Safety of Once Weekly Bortezomib In Multiple Myeloma Patients
Bringhen, S., Larocca, A., Rossi, D., Romano, A., Genuardi, M., Ria, R., Leoni, P., Patriarca, F. F., Nozzoli, C., Guglielmelli, T., et al. (2010) · Blood · doi:10.1182/blood.v116.21.3029.3029 · Cited by 29
Antony, K. K., Lewis, E., Kenny, M. T., Dulworth, J. K., Brackman, M. B., Kuzma, R., Yuh, L., Eller, M. G., & Thompson, G. A. (1991) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600800621 · Cited by 27
村山, 重., 山田, 秀., Haller, M. F., & Flament, J. (2009) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2009.03.010 · Cited by 26
Ramaswamy, P., Babl, F. E., Deasy, C., & Sharwood, L. N. (2008) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2008.00311.x · Cited by 26
Treating Relapsing Multiple Sclerosis with Subcutaneous versus Intramuscular Interferon-Beta-1a
Guo, S., Bozkaya, D., Ward, A., O’Brien, J. A., Ishak, K. J., Bennett, R., Al‐Sabbagh, A., & Meletiche, D. M. (2009) · PharmacoEconomics · doi:10.2165/00019053-200927010-00005 · Cited by 26
Stelling, J. R., Chapman, E. T., Frankfurter, D., Harris, D. H., Oskowitz, S. P., & Reindollar, R. H. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(02)04918-x · Cited by 26
Subcutaneous trastuzumab: a review of its use in HER2-positive breast cancer
Sanford, M. (2014) · Targeted Oncology · doi:10.1007/s11523-014-0313-1 · Cited by 23
Paul, M., Ram, R., Kugler, E., Farbman, L., Peck, A., Leibovici, L., Lahav, M., Yeshurun, M., Shpilberg, O., Herscovici, C., et al. (2013) · American Journal of Hematology · doi:10.1002/ajh.23622 · Cited by 22
Franciosi, M., Caccamo, L., SIMONE, P. D., et al. (2011) · Liver Transplantation · doi:10.1002/lt.22473 · Cited by 21
Galliford, J. W., Malasana, R., & Farrington, K. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh899 · Cited by 16
Neff, K., Donegan, D. M., MacMahon, J., O'Hanlon, C., Keane, N., Agha, A., Thompson, C. D., & Smith, D. C. (2014) · PubMed · Cited by 15
A Change from Subcutaneous to Intravenous Erythropoietin Increases the Cost of Anemia Therapy
McFarlane, P. A., Hillmer, M. P., & Dacouris, N. (2007) · Nephron Clinical Practice · doi:10.1159/000108649 · Cited by 13
Reggia, R., Franceschini, F., Tincani, A., & Cavazzana, I. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.141042 · Cited by 13
Yang, H., Heng, X., Liang, C., Liu, X., Du, W., Li, S., Wang, Y., Dong, Q., Li, W., Pan, Z., et al. (2014) · Journal of International Medical Research · doi:10.1177/0300060514533523 · Cited by 8
Saeedi, M., Momeni, M., Esfandbod, M., et al. (2014) · International Journal of Critical Illness and Injury Science · doi:10.4103/2229-5151.141352 · Cited by 7
Kamimura, T., Miyamoto, T., Yokota, N., Aoki, T., Ito, Y., & Akashi, K. (2013) · International Journal of Hematology · doi:10.1007/s12185-013-1469-7 · Cited by 5
Cited by
Anand, U., Dey, A., Chandel, A. K. S., Sanyal, R., Mishra, A., Pandey, D. K., De Falco, V., Upadhyay, A., Kandimalla, R., Chaudhary, A., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2022.02.007 · Cited by 1,834
Non-invasive delivery strategies for biologics
Anselmo, A. C., Gokarn, Y., & Mitragotri, S. (2019) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.183 · Cited by 665
Opioid-induced hyperalgesia: Cellular and molecular mechanisms
Roeckel, L.-A., Le Coz, G.-M., Gavériaux-Ruff, C., & Simonin, F. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.06.029 · Cited by 388
Inhaled Therapy in Respiratory Disease: The Complex Interplay of Pulmonary Kinetic Processes
Borghardt, J. M., Kloft, C., & Sharma, A. (2018) · Canadian Respiratory Journal · doi:10.1155/2018/2732017 · Cited by 304
Microneedle array systems for long-acting drug delivery
Vora, L. K., Moffatt, K., Tekko, I. A., Paredes, A. J., Volpe-Zanutto, F., Mishra, D., Peng, K., Raj Singh Thakur, R., & Donnelly, R. F. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.12.006 · Cited by 270
Metadata
- Authors
- Zhou, Q., Jin, J.-F., Zhu, L.-L., Chen, M., Xu, H.-M., Wang, H.-F., Feng, X.-Q., & Zhu, X.-P.
- Venue
- Patient Preference and Adherence
- Publisher
- Informa UK Limited
- Published
- 2015-07
- Volume
- 9
- Pages
- 923
- ISSN
- 1177-889X (ISSN-L)
- OpenAlex
- W1718641735
- Cited by
- 296
- References
- 61
- FWCI
- 14.65
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.